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bstract
Two structurally similar biphenyl compounds, biphenyl-2-carboxylic acid (B2C) and biphenyl-4-carboxylic acid (B4C), were
elected to assess their cellular cytotoxic and antimitotic behaviour in the quest of a potent anticancer compound. The HeLa and MCF-
 cell lines were used to determine the cytotoxic effect of the two biphenyl compounds using the MTT assay. Confocal microscopy
as performed to analyze the degree of nuclear condensation and fragmentation associated with depolymerized microtubules that
esult from inhibiting in  vitro  tubulin polymerization. Circular dichroism spectroscopy along with DTNB kinetics were conducted
o predict alterations in the tubulin secondary structure and global conformational changes in the tertiary structure of the protein,
espectively. Finally, a wound healing assay was employed to assess whether cellular migration was inhibited in the treated HeLa
ells. B4C imparted more cellular cytotoxicity in the HeLa and MCF-7 cell lines (IC50 ∼  4 M). B4C inhibited in  vitro  tubulin
olymerization into microtubules with an IC50 of 50 M. Confocal microscopy of treated cell indicated presumptive apoptosis,
xhibiting fragmented nuclei with significant microtubular disruption, which was confirmed by Western blot analysis. Circular
ichroism revealed a significant reduction in the -helix content of treated tubulin. DTNB kinetics showed that approximately
ix SH groups were buried in the structure. The wound healing assay revealed that B4C prevented cellular invasion. B4C had
reater cytotoxic and antimitotic effects against HeLa cells than B2C. To delineate the specific mechanism of action of B4C and its
erivatives, further research is warranted.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ttp://dx.doi.org/10.1016/j.jtusci.2014.11.011
658-3655 © 2015 The Authors. Production and hosting by Elsevier B.V. on 
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Over the past several decades, research has targeted
the cytoskeleton protein tubulin [1] to combat abnormal
cell proliferation during various types of cancer. In thesebehalf of Taibah University. This is an open access article under the
processes, small molecules have evolved in targeted can-
cer therapies [2], which have made the treatment more
successful and less toxic [2]. These molecules block the
h Unive840 S. Mukherjee et al. / Journal of Taiba
growth and spread of cancer cells by interfering with
the specific molecular pathways involved in tumour pro-
gression. Small molecules have been used for decades
in anticancer research to disrupt the molecular dynam-
ics of the tubulin–microtubule system [3]. Antimitotic
agents, such as colchicine, vinblastine, paclitaxel and
their various derivatives, bind to tubulin and inhibit the
dynamics, causing mitotic arrest and apoptosis [4–6].
Many small molecules, such as sulphonamide ER68384
[7], indanocine [3], plumbagin [6], 2-methoxyestradiol
[8], combrestatin, and podophyllotoxin [1], were dis-
covered more recently and appear to play pivotal role,
as manifested from their application on a range of can-
cer cell lines. Although many of these compounds are
in clinical trials, some limitations on their use remain,
including mutations in the tubulin genes, expression
of different tubulin isotypes with varied affinity for
drugs [3,9], mutations in cell death pathway [10] and
Fig. 1. (A) Structures of the two biphenyl compounds, B4C (1) and B2C (2), an
() cell proliferation upon exposure to the biphenyl compounds, B4C (B) an
of purified tubulin in the presence of 0(), 10 ( ), 30 ( ) and 50 ( ) M Brsity for Science 10 (2016) 839–849
over expression of drug efflux pumps, such as the
multidrug-resistant P-glycoprotein (MDR/Pgp) [3,11].
These limitations impose restrictions on the use of many
anticancer agents, and, therefore, the search for new
drugs or lead compounds is ongoing. In an effort to
identify small molecules with cytotoxic as well as antim-
itotic properties, the present study was initiated with two
biphenyl compounds, Biphenyl-2-carboxylic acid (B2C)
and biphenyl-4-carboxylic acid (B4C). Both biphenyl
compounds have two phenyl rings joined by a sin-
gle bond that rotates freely. It shares partial structural
similarity with methoxy-5-(2′,3′,4′-trimethoxyphenyl)
tropone (AC) (Fig. 1A), which binds the colchicine
binding site on tubulin and inhibits its polymerization
[12].Simple small molecules, such as phenstatin,
aminobenzophenone and their derivatives, were dis-
covered during the process of improving the in  vivo
d AC (3). Concentration-dependent inhibition of HeLa () and MCF-7
d B2C (C) using the MTT assay. Inhibition of in vitro polymerization
4C (D) and B2C (E) was monitored at 350 nm for 20 min.
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ctivity of combrestatin [13–15]. Phenstatin, with an
C50 of 3.43 M [13], affects cell viability by inhibi-
ing tubulin polymerization [13]. Similar to phenstatin,
-aminobenzophenone shows strong inhibition towards
n vitro  tubulin polymerization (IC50 = 0.3 M) [16]
nd arrests cells at the G2/M phase of the cell cycle
15].
An earlier study with 2′-acetoxybiphenyl-2-
arboxylic acid, a derivative of biphenyl-2-carboxylic
cid (B2C), reported its anti-inflammatory and anal-
esic properties [17]. Tetrazole derivatives of B2C,
fter being subjected to benzylic bromination followed
y condensation with N-methyl piperazine, induced
ignificant antimicrobial activity against two gram-
ositive (Staphylococcus  aureus, Bacillus  subtilis) and
wo gram-negative (Escherichia  coli, Salmonella  typhi)
trains, comparable to gentamycin [18].
Biphenyl-4-carboxylic acid (B4C) and its hydrazide
ydrazone derivatives were previously shown to
ave antimicrobial properties against gram-positive
nd gram-negative strains [19]. The nitro derivative
2-NO2C6H4) possesses maximal antifungal activity
against two fungal strains Candida  albicans  and
spergillus niger) compared to its chloro derivative
2-ClC6H4), which exhibits the highest antibacterial
otential [19] against two gram-positive (S.  aureus,
. subtilis) and gram-negative strains (E.  coli, Pseu-
omonas aeruginosa), respectively. There is also
 report by the same group describing the anti-
nflammatory activity of biphenyl-4-carboxylic acid
-(aryl)-4-oxothiazolidin-3-yl amides in albino rats [20].
lthough a plethora of evidence exists in support of the
ntimicrobial potential of biphenyl compounds, there are
o reports on the B2C and B4C compounds in cytotox-
city tests using cancer cell lines.
Owing to its structural simplicity that is analo-
ous to AC (Fig. 1A (3)) and has previously been
eported as an antimitotic agent, the present work was
nitiated with both B2C and B4C to study their poten-
ial as cellular cytotoxic agents by inhibiting in  vitro
ubulin polymerization. Altered HeLa cell morphology
as analyzed in presence of the biphenyl compounds
sing confocal microscopy and supported by West-
rn blotting. The wound healing assay was used to
nalyze the compounds’ ability to inhibit cell migra-
ion. Alterations in the tubulin secondary structure
n presence of biphenyl compounds were monitored
ith the aid of CD spectroscopy. Thiol group reac-
ivity of the cysteines in tubulin was performed using
TNB kinetics to monitor the global conformational
hange of protein upon binding with the biphenyl com-
ounds. However, this report is the first indicatingrsity for Science 10 (2016) 839–849 841
that B4C is a cytotoxic and antimitotic agent against
cancer cell lines by affecting the tubulin–microtubule
system.
2.  Materials  and  methods
2.1.  Materials
B4C, B2C, PIPES, EGTA, MgCl2, GTP, l-glutamic
acid, DTNB, Trypsin–EDTA and Hoechst 33258 were
all purchased from Sigma, St. Louis, MO, USA. DMSO
and glycerol were purchased from Merck, Mumbai,
India. DMEM, FBS and penicillin–streptomycin were
supplied by GIBCO, Bangalore, India. DTT, SDS and
bromophenol blue were purchased from SRL, India.
Tris, MTT and DPBS were purchased from HIMEDIA,
India. Mouse anti-  tubulin was purchased from Invit-
rogen, India and Alexa 568 from Life Technologies,
India.
2.2.  Cell  culture
HeLa and MCF-7 cells were cultured in
DMEM supplemented with 10% FBS and 2%
penicillin–streptomycin [5,21,22]. The cells were
passaged after every third day (80–90% confluency).
The cells grew exponentially at 37 ◦C in an atmosphere
maintained with 5% CO2 [7,22].
2.3.  MTT  [3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium  bromide]  assay  for  cell
viability
HeLa and MCF-7 cells (1 ×  104) were seeded in 96-
well plate and allowed to grow for 24 h [6]. The cells
were subsequently treated with different concentrations
of B2C and B4C (0, 1, 2.5, 5, 10 and 20 M) and incu-
bated for 12 h [6]. MTT (20 l of 5 mg/ml, prepared in
DPBS) was added to the treated cells and incubated until
a purple precipitate appeared. Triton-X (100 l) was
added and incubated in the dark for 2 h at room temper-
ature. The absorbance was measured on an ELISA plate
reader at 650 nm. Data were calculated as the percent of
inhibition by the following formula:
% inhibition =
[
100 −
(
At
)
×  100
]
%where At and As indicate the absorbance of the test sub-
stances and solvent control, respectively [6].
h Unive842 S. Mukherjee et al. / Journal of Taiba
2.4.  Confocal  microscopy
The effect of the biphenyl compounds on micro-
tubules and nuclei were studied by confocal microscopy.
HeLa cells were grown on poly-l-lysine-coated cover-
slips [23] at a density of 1 ×  105 cells/ml and incubated
with different concentrations of the biphenyl compounds
(B2C – 4 and 8 M; B4C – 4 M [IC50 concentration
determined using MTT assay on HeLa cell line]) for one
cell cycle (24 h) [6]. The cells were fixed using 3.7%
formaldehyde and permeabilized with ice-cold methanol
at −20 ◦C [24]. Nonspecific antibody binding sites were
blocked by incubating the cells in 2% BSA/DPBS at
37 ◦C for 30 min [7]. The cells were incubated with a
mouse monoclonal anti--tubulin antibody (1:300 dilu-
tions in 2% BSA/DPBS) for 2 h at 37 ◦C followed
by incubation with an Alexa-568-conjugated secondary
antibody (1:350 dilution in 2% BSA/DPBS) for 1 h at
37 ◦C. The cells were incubated with Hoechst 33258
(1 g/ml) for 10 min in the dark [7,25] and observed
under Zeiss LSM 510 Meta confocal microscope [6] to
visualize the nuclei.
2.5.  Western  blot  analysis
The HeLa cells were cultured in a petri dish and
treated with the test compounds for 24 h. The cells
were then lysed directly in the dish by adding lysis
buffer (160 mM Tris, pH 6.9, 200 mM DTT, 4% SDS,
20% glycerol, 0.004% bromophenol blue) along with
a protease inhibitor cocktail (Sigma, St. Louis, MO,
USA). The lysates were collected in Eppendorf tubes,
boiled for 10 min and the cellular debris was pelleted
at 13,000 ×  g. The extracts were immunoblotted with
Bcl-2, caspase 3 and -actin antibody (Santa Cruz,
CA). The resulting signals were detected using an alka-
line phosphatase-conjugated secondary antibody, which
reacted with BCIP/NBT (Genei, Bangalore, India). The
densities of the visualized bands were quantified using
ImageJ Software.
2.6.  Wound  healing  assay
This assay was performed to assess HeLa cell migra-
tion in the presence of the two biphenyl compounds.
Passaged cells were re-plated on 24-well plates and
grown to saturating confluence. A “scratch” was cre-
ated on the cell monolayer using a p200 pipette tip.
The cells were later washed with DPBS and replaced
with fresh DMEM supplemented with 10% FBS. The
cells were subsequently treated with different concen-
trations of B2C and B4C and incubated for 36 h. Imagesrsity for Science 10 (2016) 839–849
of cell migration were captured using a phase-contrast
microscope with a 10×  objective at 0, 12, 24 and 36 h
of incubation [26,27]. The obtained images were ana-
lyzed using ImageJ software. At 0 h of incubation, the
respective area formed by the wound was calculated
at 100% based on the densitometric analysis of the
selected area. The subsequent cell migration was con-
sidered to be 0% for both B4C- and B2C-treated cell
plates. The area created after wound formation was cal-
culated at 12, 24 and 36 h of incubation using ImageJ
software. In the control cells without treatment, the
gap created by the wound was completely filled after
36 h and the respective % of cell migration was con-
sidered to be 100%. The residual unfilled area in the
B4C- and B2C-treated cells was calculated at succes-
sive periods of incubation (12, 24 and 36 h) and was
extrapolated to the corresponding % of cell migra-
tion. After comparison with the control plate area (i.e.,
in absence of B4C and B2C after 36 h) where cell
migration is 100% after total gap filling, the % of cell
migration in all treated plates was plotted along the
Y-axis against the time of incubation (hours) on the
X-axis.
2.7.  Tubulin  isolation  and  puriﬁcation
The microtubule protein tubulin was isolated and
purified from goat brain using two cycles of temperature-
dependent polymerization and depolymerization with
4 M glycerol in PEM (50 mM PIPES, 1 mM EGTA and
0.5 mM MgCl2, pH 6.9) buffer in the presence of 1 mM
GTP. It was then followed by two more cycles of poly-
merization and depolymerization in 1 mM glutamate
buffer, pH 6.9, containing 1 mM EGTA and 0.5 mM
MgCl2 [7,21]. The protein concentration was determined
using the Bradford method and BSA as the standard [21].
The isolated protein was stored at −80 ◦C.
2.8.  Inhibition  of  in  vitro  tubulin  polymerization
Tubulin (15 M) was mixed with the different desired
concentrations of the biphenyl compounds and allowed
to polymerize in PEM buffer, pH 6.9, in presence of
1 mM GTP at 37 ◦C for 20 min. The 50% inhibition con-
stant (IC50) for polymerization was identified by plotting
the data points for polymerization inhibition vs.  the con-
centration of the biphenyl compounds [7].2.9.  Spectral  measurements
Circular dichroism (CD) spectra in the far-UV range
was recorded using a 0.2 cm path length cuvette in a
h University for Science 10 (2016) 839–849 843
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Table 1
IC50 value for the inhibition of in vitro tubulin polymerization and
in vitro cell cytotoxicity.
Name of small molecules IC50 of small molecules
Inhibition of tubulin
polymerization
In vitro cell
growth inhibition
Colchicine 6.5 M [3] –
AC – –
Podophyllotoxin 0.46 ± 0.02 M [30] –
Combrestatin 1.2 M [31] –
2-Methoxyestradiol Very high (60%
inhibition at 200 M)
[8]
1.2 M [8]
E7010 – 0.06–0.8 g/ml
[32]
Plumbagin 38 ± 0.5 M [6] 14.6 M [6]
Indanocine 2.85 M [3] –
Phenstatin 3.43 ± 0.70 M
[13,14]
0.437 M [13]
3-Aminobenzophenone 0.3 M [16] –
Biphenyl-4-carboxylic
acid
50 M 4 M
Biphenyl-2-carboxylic
acid
Not as effective as
B4 C
More than 20 MS. Mukherjee et al. / Journal of Taiba
ASCO J-815 spectrophotometer. Tubulin (1 M) was
reated with different concentrations of B2C and B4C
21,24] in sodium phosphate buffer, pH 7.
.10.  Titration  of  sulphhydryl  groups
Tubulin (1 M) was incubated with 10 M of B2C
nd B4C at 37 ◦C for 30 min in PEM buffer, pH 6.9.
mmediately after incubation, is the solution was brought
o 25 ◦C and mixed with DTNB at a final concentra-
ion of 400 M. Absorbance was measured continuously
t 412 nm for 60 min. The molar extinction coefficient
12,000 M−1 cm−1) of TNB was used to calculate the
umber of sulphhydryl groups that took part in the reac-
ion [21,24].
.11.  Statistical  evaluation
All of the data obtained from the MTT assay for cell
iability and the wound healing assay were confirmed
y performing independent experiments in duplicate and
re presented as the mean ±  SD [28].
.  Results  and  discussion
.1.  Effect  of  the  biphenyl  compounds  on  cell
iability and  inhibition  of  tubulin  polymerization
n vitro
From the cellular cytotoxicity studies performed on
eLa and MCF-7 cell lines, it was observed that B4C
Fig. 1B) inhibited both cell lines with IC50 values
f 4.1 ±  0.3 M and 4.3 ±  0.2 M, respectively. B4C
nhibited in  vitro  polymerization of purified tubulin in
 concentration-dependent manner, with an IC50 value
f approximately 50 M (Fig. 1D). In contrast, B2C
as an IC50 value of more than 20 M (not determined)
Fig. 1C) for both cell lines and was not able to inhibit
n vitro  polymerization of purified tubulin (Fig. 1E) as
ffectively as B4C. The IC50 values displayed by B4C are
n agreement with the IC50 values of other potent small
olecules such as phenstatin (IC50 = 3.43 ±  0.7 M)
13,14] and aminobenzophenone (0.3 M) [16], which
xhibit cytotoxicity against a range of cell lines. Compar-
ng the IC50 values of different similar small, antimitotic
ompounds (Table 1) that target the colchicine binding
ite on tubulin, it is quite clear that although B4C has
ytotoxicity and antimitotic properties, its analogue B2C
s not a sufficiently promising candidate.3.2.  Biphenyl-4-carboxylic  acid  alters  HeLa  cell
morphology
Confocal microscopy was performed to study the
alterations in microtubule network and the nuclear mor-
phology of HeLa cells upon treatment with biphenyl
compounds [6]. As shown in Fig. 2A, the microtubule
network displays abnormal organization upon treatment
with 4 M B4C (shown in white arrows, panel B)
when compared to the control cells that were treated
with vehicle (0.5% DMSO) (shown in yellow arrows)
[7]. Nuclear condensation and a ball-shaped appear-
ance of the nuclei were observed in cells treated with
B4C (IC50 – 4 M [determined by the MTT assay
on HeLa cells]) (shown in white arrows, panel A),
whereas in the control cells, normal elongated nuclei
(shown in yellow arrows) were observed. The effect
was more drastic with 8 M B4C (2IC50), which con-
siderably decreased the cytoskeletal network (shown
in white arrows, panel B) and was accompanied by
nuclear condensation and fragmentation. This supported
the hypothesis that B4C induced apoptotic cell death
[7]. Similar observations are shown in earlier studies by
Renu Mohan et al. in HeLa cells treated with Compound
4 (a sulphonamide representative). In contrast, there
were no significant alterations in the microtubule net-
work or the nuclear structure in cells treated with 4 M
844 S. Mukherjee et al. / Journal of Taibah University for Science 10 (2016) 839–849
Fig. 2. Effect of the biphenyl compounds on HeLa cells. (A) The cells were incubated with 0, 4 and 8 M B4C and 0, 4 and 8 M B2C for 24 h.
The cells were then processed for Alexa/Hoechst staining. Hoechst-stained nuclei are in blue (panel A) and Alexa 568-stained microtubules are in
red (panel B). The yellow arrows indicate normal nuclei and microtubule network. The white arrows indicate the apoptotic nuclei and damaged
microtubule network. (B) The cells were incubated with 0 and 4 M B4C for 24 h. The higher magnification images clearly showed apoptotic nuclei
and the damaged microtubule network at the IC50 concentration of B4C in comparison to the control cells.
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cig. 3. Western blot of HeLa cell lysates treated with 4 M B2C (lane
) and B4C (lane 3) in comparison with the untreated control (lane 1).
r 8 M B2C, resembling the control. This revealed a
educed potency of B2C compared to B4C when used
n equivalent amounts in HeLa cells. However, treat-
ent with 8 M B2C resulted in very few cells with an
ltered microtubule network and it induced the forma-
ion of apoptotic bodies, although they were much fewer
n number compared to the normal cells. For a better
erception of the abnormal microtubular organization,
his same was performed with higher resolution using
ontrol and 4 M B4C-treated HeLa cells. The micro-
ubules in control (vehicle-treated) HeLa cells were
ell-spread with distinctly visible peripheral micro-
ubules (Fig. 2B, panel 1). In the presence of 4 M
IC50) B4C, the microtubules were markedly depolymer-
zed and appeared to be strongly diminished (Fig. 2B,
anel 2) compared to the control cells (Fig. 2B, panel
). B2C-treated cells, conversely, were unable to pro-
uce any significant change in the cytoskeletal structure
nd had a similar morphology to control cells (data not
hown).
.3.  Biphenyl-4-carboxylic  acid  induces  apoptosis
n HeLa  cells
Bcl-2 family proteins are the key regulators of mito-
hondrial outer membrane permeabilization (MOMP),
hich governs the release of pro-apoptotic molecules,
ncluding cytochrome c, to promote caspase activation
nd apoptosis [29]. To explore whether both com-
ounds induce apoptosis, the effect of B4C and B2C
0 and 4 M, respectively) on Bcl-2 protein expres-
ion was examined (Fig. 3). Exposure of the HeLa
ell line to B2C increased the basal expression of
he Bcl-2 protein. This, in turn, down-regulated cas-
ase 3 expression, suggesting that Bcl-2 mediated
he inhibition of B2C-induced apoptosis. In contrast,
4C treatment down-regulated Bcl-2 expression and
ugmented the expression of cleaved caspase 3, indi-
ating that the cells were destined for apoptosis. Thesersity for Science 10 (2016) 839–849 845
findings were supported by the changes in HeLa cell
morphology as observed from confocal microscopy.
Finally, these results indicate Bcl-2 mediated the effect
of B4C and B2C on apoptosis induction in HeLa
cells.
3.4.  Effect  of  the  biphenyl  compounds  on  inhibiting
in vitro  cell  migration  using  a  wound  healing  assay
The fundamental step in the malignant transition
of a tumour is angiogenesis, which requires the for-
mation of new blood vessels from pre-existing ones
and involves the dissolution of the basement mem-
brane underlying the endothelial cells, the migration of
endothelial cells, adhesion, proliferation as well as tube
formation [30]. It can be studied in  vitro  by measur-
ing cell migration. To determine whether the biphenyl
compounds were inhibitors, a scratch wound was cre-
ated completely confluent HeLa cells that were then
treated with 2, 4 and 6 M of B2C and B4C, respec-
tively. Migration images of HeLa cells were analyzed
over a period of 36 h (Fig. 4A and C). The treated cells
showed 60.35%, 64.29% and 68.82% cell migration with
2 M B2C (Fig. 4B), and 2.83%, 6.6% and 9.93% cell
migration with 2 M B4C (Fig. 4D). Cell migration
was decreased to 1.78%, 5.62% and 7.37% for 4 M
B4C and 44.39%, 54.06% and 60.55% for 4 M B2C
compared to 43.74%, 67.12% and 84.72% for untreated
cells at 12, 24 and 36 h, respectively. Finally, cells
treated with 6 M B4C showed 0.69%, 3.55% and 5.89%
cell migration, while and cells treated with 6 M B2C
showed 38.12%, 51.74% and 58.5% cell migration at
the respective time points. The above data indicates that
B2C exhibited weaker potency than B4C as an inhibitor
of cell migration, which is important for their future
prospects.
3.5.  Alteration  of  the  tubulin  secondary  structure  in
the presence  of  biphenyl-4-carboxylic  acid
CD spectral analysis was performed to discern the
structural changes in purified tubulin upon binding to
the biphenyl compounds. B4C significantly reduced
the molar ellipticity of tubulin in the far-UV range,
indicating alterations in the secondary structure, espe-
cially the -helix content of bound tubulin compared
to unbound tubulin (Fig. 5A). This is in accord with
previous results from Gireesh et al. using tubulin and a
dose-dependent range of CIL-102 [21]. However, B2C-
bound tubulin did not show any significant reduction
in the molar ellipticity compared to unbound tubu-
lin at low concentrations (2 M) but did show some
846 S. Mukherjee et al. / Journal of Taibah University for Science 10 (2016) 839–849
Fig. 4. Wound healing assay of HeLa cells in the presence of the biphenyl compounds. Altered cell migration after treatment with 0 (control), 2, 4
 percen
ed at 1
in tubulin upon binding to colchicine [24]. Earlier stud-and 6 M B2C (A) and B4C (C) was imaged at 0, 12, 24 and 36 h. The
(), 2 ( ), 4 ( ) and 6 ( ) M B2C (B) and B4C (D) was determin
reduction in molar ellipticity at high concentrations
(20 M) (Fig. 5B), although it was not significant when
compared to that of B4C-bound tubulin at the same con-
centrations.
3.6.  Biphenyl-4-carboxylic  acid  changes  the  global
conformation  of  tubulin  upon  binding
DTNB kinetics is frequently used to evaluate protein
conformation during folding and unfolding due to com-
pound binding. DTNB kinetics is used to analyze the
relationship between the loss of drug binding activity
towards a target protein due to ageing [24]. DTNB kinet-
ics measures the optical density (412 nm) obtained due
to release of TNB− over a period of time after proteins
are treated with DTNB. In this case, DTNB kinetics were
performed to verify the global conformational changestage of wound area filling due to cell migration after treatment with 0
2, 24 and 36 h.
upon the binding of the biphenyl compounds to purified
tubulin (Fig. 5C). The tubulin–B4C complex was treated
with DTNB with the objective of identifying the number
of exposed and buried cysteine ( SH) groups upon bind-
ing of the biphenyl compounds. B4C-bound tubulin had
approximately 14 thiol groups exposed compared to 20
in unbound tubulin, whereas the tubulin–B2C complex
had approximately 17 thiol groups exposed. This clearly
indicated that only 3 cysteine residues were protected
due to structural changes upon the binding of B2C to
tubulin, whereas B4C protected 6 cysteine residues. The
observations confirmed earlier results that showed com-
plete protection of 1.6 SH groups of cysteine residuesies by Gireesh et al. showed that 1.6 and 2.8 cysteine
thiol group in tubulin were buried in the presence of 15
and 30 M CIL-102, respectively [21].
S. Mukherjee et al. / Journal of Taibah University for Science 10 (2016) 839–849 847
Fig. 5. Global effects of biphenyl compound binding to purified tubulin. The far-UV spectra of 1 M tubulin in the absence ( ) and presence of
2 ( ) and 20 ( ) M B4C (A) and B2C (B) in phosphate buffer (pH 7) are shown. The spectra shown are the average of three scans. (C) Tubulin
(1 M) was incubated with 0 ( ) and 10 M B2C ( ) and B4C ( ). DTNB (400 M) was added to the reaction mixture and absorbance was
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Bontinuously monitored at 412 nm over a period of 3600 seconds. T
umber of SH groups reacted per tubulin dimer.
.  Conclusions
Biphenyl-2-carboxylic acid and biphenyl-4-
arboxylic acid exhibited differential activity in the
ellular cytotoxicity assay and in inhibiting in  vitro
ubulin polymerization. B4C affects cellular viability
n both HeLa and MCF-7 cells, whereas B2C appeared
o be much less efficient. Similarly, B2C exhibited
ower potency in inhibiting in  vitro  tubulin polymeriza-
ion, whereas B4C decreased tubulin polymerization
n a concentration-dependent manner. B4C altered
he microtubule structure as evident from confocalicroscopy, which showed nuclear condensation
nd fragmentation, indicative of apoptosis, and was
upported by the Western blot analysis. Compared to
4C, B2C was not potent enough to produce similarriment was performed in PEM buffer at 25 ◦C. The inset shows the
changes. While B4C and B2C were tested in the wound
healing assay, the results showed that B4C was better
able to inhibit cell migration than B2C. CD spectral
analysis of the B4C–tubulin complex demonstrated a
reduction in the alpha helix content of tubulin that was
also accompanied by buried thiol groups of cysteines
in DTNB kinetics. On the other hand, B2C affects
the tubulin secondary structure to a lesser extent and
exposes more cysteine residues in DTNB kinetics,
indicating a reduced interaction.
Structural analysis demonstrated that B4C (Fig. 1A
(1)) has two phenyl rings joined with a single bond
having a carboxyl group at para position, which allows
free rotation of the two phenyl rings across the single
bond. Conversely, B2C (Fig. 1A (2)) possesses a simi-
lar structure, with the carboxyl group at ortho position
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with respect to the single bond, which may induce steric
constraints that hinder the free rotation of the phenyl
rings across the single bond. Hypothetically, the restric-
tion in free rotation of the two phenyl rings of B2C may
be the reason behind its reduced potency compared to
B4C, which needs to be explored further with different
derivatives of these compounds. However, the present
finding is the first report on the cytotoxic properties and
tubulin polymerization inhibition of B4C, which is to be
explored further in the future to delineate its mechanism
of action.
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